The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The Trump White House has pushed for drastic cuts to global HIV prevention efforts; now it's reportedly eyeing cuts at home, ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

THURSDAY, March 20, 2025 (HealthDay News) -- The Trump administration is weighing elimination of the U.S. Centers for Disease ...

Survey data suggests that over a third of organizations that relied on US funding for HIV services had already closed by ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

It’s a tapu subject,” said Milly Stewart, a specialist indigenous service provider pushing for more public education around ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection ... AIDS arrived as American politics took a sharp conservative turn with the election of President ...

After years of success reducing the number of new cases of AIDS, experts fear the change in government policy could mean this ...